1995 Budget Draws Praise -- And Concerns

Sidebar:Federal Research Funding Though many express general satisfaction with allocations, some observers warn of tough funding battles ahead The 1995 federal budget process has produced its traditional share of beneficiaries and victims, champions and critics. Some, for example, are heartened by a 14 percent funding increase for the National Science Foundation, while others view a modest budget raise for the National Institutes

Written byBarton Reppert
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Sidebar:Federal Research Funding


Though many express general satisfaction with allocations, some observers warn of tough funding battles ahead
The 1995 federal budget process has produced its traditional share of beneficiaries and victims, champions and critics. Some, for example, are heartened by a 14 percent funding increase for the National Science Foundation, while others view a modest budget raise for the National Institutes of Health as woefully inadequate.

In general, many officials of scientific associations and other science-policy watchers are expressing satisfaction with this year's congressional appropriations for research funding.

Several other observers, however, see in this and other recent budget go-rounds indications that do not bode well for the future. They caution that the U.S. research community will need to redouble its lobbying efforts and push for sustained support in the next budget year, in view of increasingly tight caps on federal discretionary spending.

Rep. George E. Brown, Jr. (D-Calif.), ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies